The cytogenetic systems market is projected to grow from USD 2.3 billion in 2025 to USD 6.6 billion by 2035, at a CAGR of 11.0%. Fluorescence In Situ Hybridization (FISH) will dominate with a 38.5% market share, while genetic disorders will lead the application segment with a 41.7% share.